CHRNA5 and hepatocellular carcinoma: Consistent with their study, our study also indicated that CHRNA5 could maintain the stemness properties of HCC cells by regulating stemness-associated genes, to which the regulatory role of CHRNA5 in sorafenib sensitivity could be partially attributed.